1 INTRODUCTION Parkinson's disease (PD) is a progressive neurodegenerative disorder impacting approximately 1% of the population aged more than 60 years.1 Evidence suggests genotype–phenotype correlations in patients with PD who have specific genetic mutations.2-4 Compared with idiopathic PD (iPD), glucosylceramidase β PD (GBA-PD) was associated with motor impairment at a younger age, higher incidence and earlier onset of cognitive impairment, and more psychiatric symptoms, and leucine-rich...